Lab Partnering Service Discovery

Michael Connolly is a Principal Scientific Engineering Associate at the Molecular Foundry at Lawrence Berkeley National Laboratory and an organic chemist with 20+ years of expertise in combinatorial and automated synthesis methods and nanomaterial discovery. His research focus is the development of combinatorial discovery technologies and new biopolymer nanomaterials. He has developed a class of bio-inspired polymer called ‘peptoids’ that have found utility in drug discovery, drug delivery, diagnostics, and materials science. Key contributions included the development of new synthetic methods, new sequencing, and characterization methods for peptoids.

Additional information available at this link.

COVID-19-related research: "Scientists Aim Gene-Targeting Breakthrough against COVID-19" (cellular delivery system/anti-viral agent)

Dr. Brunecky is a research scientist with a background in pharmacology, drug discovery, diagnostics, and sensor development.

At the National Renewable Energy Laboratory, Dr. Brunecky's interests include the novel mechanisms by which newly discovered multimodular cellulase enzymes such as CelA interact with and degrade crystalline cellulose as well as whole biomass with an aim to design and optimize enhanced cellulase systems for overcoming biomass recalcitrance as well as the possible uses of glycoside hydrolase enzymes expressed in-planta to reduce plant cell wall recalcitrance.

For more information about Dr. Brunecky's research interests at the National Renewable Energy Laboratory, please find a summary here.